Effect of Breathing Exercise During Peripheral Intravenous Catheter

December 23, 2022 updated by: Sevda Korkut, TC Erciyes University

Effect of Breathing Exercise During Peripheral Intravenous Catheter Implementation on Pain, Anxiety, and Patient Satisfaction

This study was carried out to determine the effect of breathing exercise performed during peripheral intravenous catheter (PIVC) application on pain, anxiety and patient satisfaction.

The study was completed as a randomized controlled experimental study with a total of 130 individuals who met the inclusion criteria. The Descriptive Characteristics Questionnaire, the State-Trait Anxiety Inventory, and the Numerical Rating Scale were used to collect the data of the study. In addition, Algometer (66 Lb/30 Kg) device was used to evaluate the pain pressure threshold in determining the individuals to be included in the research sample. The individuals in the intervention group were given diaphragmatic breathing exercise while applying the catheter, and the individuals in the control group were inserted without any application.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study was carried out to determine the effect of breathing exercise performed during peripheral intravenous catheter (PIVC) application on pain, anxiety and patient satisfaction.

The study was completed as a randomized controlled experimental study with a total of 130 individuals who met the inclusion criteria, 65 of whom were in the intervention group and 65 in the control group. Ethics committee approval, institutional permission, and written informed consent from individuals were obtained in the study. The Descriptive Characteristics Questionnaire, the State-Trait Anxiety Inventory, and the Numerical Rating Scale were used to collect the data of the study. In addition, Algometer (66 Lb/30 Kg) device was used to evaluate the pain pressure threshold in determining the individuals to be included in the research sample. The individuals in the intervention group were given diaphragmatic breathing exercise while applying the catheter, and the individuals in the control group were inserted without any application.

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kayseri, Turkey, 38039
        • Erciyes University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • able to speak and understand Turkish,
  • between the ages of 18-65,
  • having orientation to place and time,
  • without any psychiatric disease and hearing problems,
  • not using central nervous system drugs,
  • people who having PIVC indication,
  • no analgesic or anesthetic agent was applied 24 hours before PIVC application,
  • not have any pain in any part of the body that may affect the results of the study,
  • no PIVC experience in the last month,
  • 20-G catheter will be applied,
  • pressure pain threshold mean of 8-16 pounds (Lb), (11) individuals who volunteered to participate in the study.

Exclusion Criteria:

  • Infection in the area where PIVC will be applied, -having previous operation, scarring, psoriasis, active dermatitis in the area - -
  • where PIVC will be applied,
  • with peripheral nerve disease,
  • no catheter applied to the forearm veins,
  • having diabetes,
  • with peripheral neuropathy,
  • diagnosed with cancer,
  • receiving cancer treatment,
  • with respiratory disease,
  • who have an obstacle to breathing exercise,
  • in the post-surgical period,
  • individuals who did not volunteer to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Breathing exercise
Diaphragmatic breathing exercises were taught to the individuals by the researcher and they were asked to start breathing exercises before starting PIVC. While the PIVC was being placed, the individuals continued the breathing exercise and the breathing exercise was terminated at the end of the application.
No Intervention: Control
Standard practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: 3 minutes after catheter insertion
Pain level measured with Numeric Rating Scale. The number "0" on the scale means that they do not feel any pain and the number "10" refers to the worst pain.
3 minutes after catheter insertion
Anxiety level
Time Frame: 3 minutes after catheter insertion
Anxiety level measured with Numeric Rating Scale. The number "0" on the scale means that they do not feel any anxiety and the number "10" refers to the highest level of anxiety.
3 minutes after catheter insertion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction level
Time Frame: 3 minutes after catheter insertion
Satisfaction level measured with Numeric Rating Scale. The number "0" in the scale indicates that the participants are not at all satisfied with the application, and the number "10" indicates the highest level of satisfaction.
3 minutes after catheter insertion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sevda Korkut, TC Erciyes University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2022

Primary Completion (Actual)

July 28, 2022

Study Completion (Actual)

July 28, 2022

Study Registration Dates

First Submitted

December 15, 2022

First Submitted That Met QC Criteria

December 23, 2022

First Posted (Estimate)

January 11, 2023

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

December 23, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venipuncture

Clinical Trials on Breathing exercise

Subscribe